INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
HOUSE PTR/SaleVerified data

Kevin Hern sold BSX

Joint · BOSTON SCIENTIFIC CORP · Boston Scientific Corporation Common Stock

Side
SELL
Value range
$15K – $50K
Shares
Not disclosed
Price
—
Executed
Aug 31, 2026
Disclosed
Sep 25, 2026
Disclosure timeline25 days from execution to publication · legal deadline 45 days
Aug 31 executedSep 25, 2026 disclosed

BSX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Sale

  • Relative size+6 / 25

    Disclosed range starting at $15K

  • Filing timing0 / 15

    Disclosed 25 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BSX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    Kevin HernRDependent child
    BSXBOSTON SCIENTIFIC CORP
    Sale
    		SELL$1,001 – $15KSep 3, 2026Sep 25, 2026
    traded Sep 3, 2026
    		+22dHOUSE PTR

    Evidence

    26
    Kevin HernRJoint
    BSXBOSTON SCIENTIFIC CORP
    Partial sale
    		SELL$50K – $100KSep 4, 2026Sep 25, 2026
    traded Sep 4, 2026
    		+21dHOUSE PTR

    Evidence

    26
    Kevin HernRJoint
    BSXBOSTON SCIENTIFIC CORP
    Sale
    		SELL$50K – $100KSep 9, 2026Sep 25, 2026
    traded Sep 9, 2026
    		+16dHOUSE PTR

    Evidence

    16
    Kevin HernRDependent child
    BSXBOSTON SCIENTIFIC CORP
    Sale
    		SELL$1,001 – $15KSep 3, 2026Sep 25, 2026
    traded Sep 3, 2026
    		+22dHOUSE PTR

    Evidence

    16
    Kevin HernRDependent child
    BSXBOSTON SCIENTIFIC CORP
    Sale
    		SELL$1,001 – $15KSep 3, 2026Sep 25, 2026
    traded Sep 3, 2026
    		+22dHOUSE PTR

    Evidence

    17
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KAug 18, 2026Sep 10, 2026
    traded Aug 18, 2026
    		+23dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KJun 5, 2026Jul 2, 2026
    traded Jun 5, 2026
    		+27dHOUSE PTR

    Evidence

    27
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Partial sale
    		SELL$1,001 – $15KJun 5, 2026Jul 2, 2026
    traded Jun 5, 2026
    		+27dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KMay 29, 2026Jun 8, 2026
    traded May 29, 2026
    		+10dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KMay 19, 2026Jun 8, 2026
    traded May 19, 2026
    		+20dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KMay 11, 2026Jun 8, 2026
    traded May 11, 2026
    		+28dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KFeb 10, 2026Mar 9, 2026
    traded Feb 10, 2026
    		+27dHOUSE PTR

    Evidence

    24
    Gilbert Ray Cisneros, Jr.DSelf
    BSXBOSTON SCIENTIFIC CORP
    Purchase
    		BUY$1,001 – $15KJan 30, 2026Feb 13, 2026
    traded Jan 30, 2026
    		+14dHOUSE PTR

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035491

    Timestamps

    Event (reported)
    Aug 31, 2026
    Published
    Sep 25, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 5, 07:36 UTC

    Extracted facts

    Filer
    Kevin Hern
    Role
    JointAs filed: “JT”
    Transaction
    SaleAs filed: “S”
    Asset
    Boston Scientific Corporation Common Stock
    Ticker
    BSX
    Reported value
    $15K – $50KAs filed: “$15,001 - $50,000”
    Execution date (reported)
    Aug 31, 2026
    Notification date (reported)
    Sep 15, 2026
    Days from execution to publication
    25

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $15,001
    • High: $50,000

    = $32,501

    What this establishes

    Kevin Hern reported a sale of Boston Scientific Corporation Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Joint
    Kevin Hernbioguide:H001082
    Issuer
    BOSTON SCIENTIFIC CORPcik:0000885725

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.